Novo Nordisk, Actavis End PrandiMet Patent Spat

Law360, New York (November 9, 2010, 2:34 PM EST) -- Novo Nordisk A/S and Actavis Pharma Manufacturing Pvt. Ltd. LLC have resolved a patent infringement suit over Actavis Pharma's bid for regulatory approval to make and sell a generic version of the diabetes drug PrandiMet.

Judge Paul G. Gardephe of the U.S. District Court for the Southern District of New York signed off on a stipulation and order of dismissal in the case Friday.

Novo Nordisk slapped Actavis Pharma and Actavis Inc. with a lawsuit in October 2009, after Actaviz Pharma filed an Abbreviated New Drug...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.